Aphasia — Effect of Communication Partner Training Program for the Management of Persons With Aphasia
Citation(s)
Chang HF, Power E, O'Halloran R, Foster A Stroke communication partner training: a national survey of 122 clinicians on current practice patterns and perceived implementation barriers and facilitators. Int J Lang Commun Disord. 2018 Nov;53(6):1094-1109. doi: 10.1111/1460-6984.12421. Epub 2018 Aug 27.
Croteau C, McMahon-Morin P, Le Dorze G, Baril G Impact of aphasia on communication in couples. Int J Lang Commun Disord. 2020 Jul;55(4):547-557. doi: 10.1111/1460-6984.12537. Epub 2020 May 13.
Johansson MB, Carlsson M, Sonnander K Communication difficulties and the use of communication strategies: from the perspective of individuals with aphasia. Int J Lang Commun Disord. 2012 Mar-Apr;47(2):144-55. doi: 10.1111/j.1460-6984.2011.00089.x. Epub 2011 Oct 25.
Kagan A, Black SE, Duchan FJ, Simmons-Mackie N, Square P Training volunteers as conversation partners using "Supported Conversation for Adults with Aphasia" (SCA): a controlled trial. J Speech Lang Hear Res. 2001 Jun;44(3):624-38. doi: 10.1044/1092-4388(2001/051).
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
